1. Immune checkpoint inhibitor-induced sarcoidosis-like granulomas

   • Pooja H. Rambhia
   • Barbara Reichert
   • Meg R. Gerstenblith

   Review Article 18 July 2019 Pages: 1171 - 1181

   

2. Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy

   • Yuichi Kibe
   • Naoki Nakamura
   • Tetsuo Akimoto

   Original Article 09 July 2019 Pages: 1182 - 1189

   

3. Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer

   • Kozo Miyatani
   • Hiroaki Saito
   • Yoshiyuki Fujiwara

   Original Article 18 May 2019 Pages: 1190 - 1196

   

4. Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study

   • Seiichiro Mitani
   • Shigenori Kadowaki
   • Kei Muro

   Original Article 31 May 2019 Pages: 1197 - 1203

   

5. Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)

   • Shun Sasaki
   • Eiji Oki
   • Yoshihiko Maehara

   OriginalPaper 06 May 2019 Pages: 1204 - 1213

   

6. Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)

   • Toshikazu Moriwaki
   • Yoshinori Sakai
   • Ichinosuke Hyodo

   Original Article 14 May 2019 Pages: 1214 - 1222

   

7. Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

   • Nobuaki Suzuki
   • Shoichi Hazama
   • Masazumi Okajima

   Original Article Open access 29 May 2019 Pages: 1223 - 1230

   

8. Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer

   • Nobushige Takeshita
   • Masafumi Otsuka
   • Satoshi Fukasawa

   Original Article 28 May 2019 Pages: 1231 - 1237

   

9. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer

   • Sahyun Pak
   • Dalsan You
   • Hanjong Ahn

   Original Article 13 May 2019 Pages: 1238 - 1246

   

10. Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation

    • Rihito Aizawa
    • Kenji Takayama
    • Takashi Mizowaki

    Original Article Open access 31 May 2019 Pages: 1247 - 1255

    

11. Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer

    • Ayumi Shikama
    • Takeo Minaguchi
    • Toyomi Satoh

    Original Article 16 May 2019 Pages: 1256 - 1263

    

12. Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants

    • Jung Mi Byun
    • Hwa Jin Cho
    • Dae Hoon Jeong

    Original Article 28 May 2019 Pages: 1264 - 1272

    

13. Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma

    • Kazuki Takasaki
    • Morikazu Miyamoto
    • Kenichi Furuya

    Original Article 09 May 2019 Pages: 1273 - 1283

    

14. A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

    • Hiroyuki Fujiwara
    • Kimio Ushijima
    • Mitsuaki Suzuki

    Original Article 24 May 2019 Pages: 1284 - 1291

    

15. Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma

    • Mitsuaki Tatsumi
    • Kayako Isohashi
    • Jun Hatazawa

    Original Article 05 June 2019 Pages: 1292 - 1300

    

16. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma

    • Cem Mirili
    • Ali Yılmaz
    • Salim Basol Tekin

    Original Article 09 May 2019 Pages: 1301 - 1310

    

17. Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma

    • Toru Wakamatsu
    • Shigeki Kakunaga
    • Takafumi Ueda

    Original Article 13 June 2019 Pages: 1311 - 1319

    

18. A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types

    • Masaya Hattori
    • Sumitaka Hagiwara
    • Hiroji Iwata

    Original Article 01 June 2019 Pages: 1320 - 1327

    

19. Familial cancer of unknown primary

    • Elie Rassy
    • Joseph Kattan
    • Nicholas Pavlidis

    Letter to the Editor 15 June 2019 Pages: 1328 - 1331